ReP USP - Resultado da busca

Monografia/livro
Purinergic Signaling in Neurodevelopment, Neuroinflammation and Neurodegeneration (2023)
Ulrich, Henning ; Illes, Peter ; Glaser, Talita
Unidade: IQ
Subjects: RECEPTORES, NUCLEOTÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ULRICH, Henning e ILLES, Peter e GLASER, Talita. Purinergic Signaling in Neurodevelopment, Neuroinflammation and Neurodegeneration. . Cham: Springer. . Acesso em: 18 nov. 2024. , 2023
APA
Ulrich, H., Illes, P., & Glaser, T. (2023). Purinergic Signaling in Neurodevelopment, Neuroinflammation and Neurodegeneration. Cham: Springer.
NLM
Ulrich H, Illes P, Glaser T. Purinergic Signaling in Neurodevelopment, Neuroinflammation and Neurodegeneration. 2023 ;[citado 2024 nov. 18 ]
Vancouver
Ulrich H, Illes P, Glaser T. Purinergic Signaling in Neurodevelopment, Neuroinflammation and Neurodegeneration. 2023 ;[citado 2024 nov. 18 ]
Artigo de periodico
Purinergic signaling in cognitive impairment and neuropsychiatric symptoms of Alzheimer’s disease (2023)
Ribeiro, Deidiane Elisa ; Petiz, Lyvia Lintzmaier ; Glaser, Talita ; Giacomelli, Ágatha Oliveira ; Andrejew, Roberta ; Saab, Fernando de Azevedo Ribeiro; Milanis, Milena da Silva ; Campos, Henrique Correia; Sampaio, Vanessa Fernandes Arnaud ; La Banca, Sophia; Longo, Beatriz Monteiro ; Lameu, Claudiana ; Tang, Yong; Resende, Rodrigo Ribeiro ; Ferreira, Sergio T ; Ulrich, Henning
Source: Neuropharmacology. Unidade: IQ
Subjects: NEUROPSIQUIATRIA, DOENÇA DE ALZHEIMER, DEPRESSÃO, TRANSTORNOS DO SONO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIBEIRO, Deidiane Elisa et al. Purinergic signaling in cognitive impairment and neuropsychiatric symptoms of Alzheimer’s disease. Neuropharmacology, v. 226, p. 1-16 art. 109371, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2022.109371. Acesso em: 18 nov. 2024.
APA
Ribeiro, D. E., Petiz, L. L., Glaser, T., Giacomelli, Á. O., Andrejew, R., Saab, F. de A. R., et al. (2023). Purinergic signaling in cognitive impairment and neuropsychiatric symptoms of Alzheimer’s disease. Neuropharmacology, 226, 1-16 art. 109371. doi:10.1016/j.neuropharm.2022.109371
NLM
Ribeiro DE, Petiz LL, Glaser T, Giacomelli ÁO, Andrejew R, Saab F de AR, Milanis M da S, Campos HC, Sampaio VFA, La Banca S, Longo BM, Lameu C, Tang Y, Resende RR, Ferreira ST, Ulrich H. Purinergic signaling in cognitive impairment and neuropsychiatric symptoms of Alzheimer’s disease [Internet]. Neuropharmacology. 2023 ; 226 1-16 art. 109371.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2022.109371
Vancouver
Ribeiro DE, Petiz LL, Glaser T, Giacomelli ÁO, Andrejew R, Saab F de AR, Milanis M da S, Campos HC, Sampaio VFA, La Banca S, Longo BM, Lameu C, Tang Y, Resende RR, Ferreira ST, Ulrich H. Purinergic signaling in cognitive impairment and neuropsychiatric symptoms of Alzheimer’s disease [Internet]. Neuropharmacology. 2023 ; 226 1-16 art. 109371.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2022.109371
Artigo de periodico
Various facets of excitotoxicity (2022)
Glaser, Talita ; Silva, Jean Bezerra ; Juvenal, Guilherme Araújo ; Maiolini, Pedro Negrão; Turrini, Natalia ; Petiz, Lyvia Lintzmaier ; Marques, Lucas Bonfim; Ribeiro, Deidiane Elisa ; Ye, Qing; Tang, Yong ; Ulrich, Henning
Source: Exploration of Neuroprotective Therapy. Unidade: IQ
Subjects: MITOCÔNDRIAS, AMINOÁCIDOS EXCITATÓRIOS, GLUTAMATOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GLASER, Talita et al. Various facets of excitotoxicity. Exploration of Neuroprotective Therapy, v. 2, p. 36–64, 2022Tradução . . Disponível em: https://doi.org/10.37349/ent.2022.00017. Acesso em: 18 nov. 2024.
APA
Glaser, T., Silva, J. B., Juvenal, G. A., Maiolini, P. N., Turrini, N., Petiz, L. L., et al. (2022). Various facets of excitotoxicity. Exploration of Neuroprotective Therapy, 2, 36–64. doi:10.37349/ent.2022.00017
NLM
Glaser T, Silva JB, Juvenal GA, Maiolini PN, Turrini N, Petiz LL, Marques LB, Ribeiro DE, Ye Q, Tang Y, Ulrich H. Various facets of excitotoxicity [Internet]. Exploration of Neuroprotective Therapy. 2022 ; 2 36–64.[citado 2024 nov. 18 ] Available from: https://doi.org/10.37349/ent.2022.00017
Vancouver
Glaser T, Silva JB, Juvenal GA, Maiolini PN, Turrini N, Petiz LL, Marques LB, Ribeiro DE, Ye Q, Tang Y, Ulrich H. Various facets of excitotoxicity [Internet]. Exploration of Neuroprotective Therapy. 2022 ; 2 36–64.[citado 2024 nov. 18 ] Available from: https://doi.org/10.37349/ent.2022.00017
Artigo de periodico
Purinergic receptors in basal ganglia diseases: shared molecular Mechanisms between huntington’s and parkinson’s disease (2020)
Glaser, Talita ; Andrejew, Roberta ; Giacomelli, Ágatha Oliveira ; Ribeiro, Deidiane Elisa ; Marques, Lucas Bonfim; Ye, Qing; Ren, Wen-Jing; Semyanov, Alexey; Illes, Peter; Tang, Yong; Ulrich, Henning
Source: Neuroscience Bulletin. Unidade: IQ
Subjects: RECEPTORES, DOENÇA DE PARKINSON, DOENÇAS DOS GÂNGLIOS DE BASE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GLASER, Talita et al. Purinergic receptors in basal ganglia diseases: shared molecular Mechanisms between huntington’s and parkinson’s disease. Neuroscience Bulletin, v. 36, n. 11, p. 1299–1314, 2020Tradução . . Disponível em: https://doi.org/10.1007/s12264-020-00582-8. Acesso em: 18 nov. 2024.
APA
Glaser, T., Andrejew, R., Giacomelli, Á. O., Ribeiro, D. E., Marques, L. B., Ye, Q., et al. (2020). Purinergic receptors in basal ganglia diseases: shared molecular Mechanisms between huntington’s and parkinson’s disease. Neuroscience Bulletin, 36( 11), 1299–1314. doi:10.1007/s12264-020-00582-8
NLM
Glaser T, Andrejew R, Giacomelli ÁO, Ribeiro DE, Marques LB, Ye Q, Ren W-J, Semyanov A, Illes P, Tang Y, Ulrich H. Purinergic receptors in basal ganglia diseases: shared molecular Mechanisms between huntington’s and parkinson’s disease [Internet]. Neuroscience Bulletin. 2020 ; 36( 11): 1299–1314.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s12264-020-00582-8
Vancouver
Glaser T, Andrejew R, Giacomelli ÁO, Ribeiro DE, Marques LB, Ye Q, Ren W-J, Semyanov A, Illes P, Tang Y, Ulrich H. Purinergic receptors in basal ganglia diseases: shared molecular Mechanisms between huntington’s and parkinson’s disease [Internet]. Neuroscience Bulletin. 2020 ; 36( 11): 1299–1314.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s12264-020-00582-8

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Funding Agencies

Non normalized affiliation